Vivani Medical Inc

Research Vivani Medical Inc (VANI) on Bullrun: market cap USD 126.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 126.96M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0USD 26.61M-USD 25.49Mn/a-0.43USD 16.23MUSD 18.86MUSD 15.73M
FY2024USD 0USD 23.49M-USD 21.34Mn/a-0.43USD 18.35MUSD 19.31MUSD 17.61M
FY2023n/aUSD 25.65M-USD 24.59Mn/a-0.5USD 20.65MUSD 20.70MUSD 20.76M
FY2022n/a-USD 13.89M-USD 19.13Mn/an/aUSD 45.08MUSD 1.43MUSD 44.31M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 126.96Mn/an/an/a
20252025-12-31USD 94.01Mn/an/an/a
20242024-12-31USD 68.71Mn/an/an/a
20232023-12-29USD 52.05Mn/an/an/a
20222022-12-30USD 43.13Mn/an/an/a

About Vivani Medical Inc

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Vivani Medical Inc's market cap?

Vivani Medical Inc's market capitalization is USD 126.96M.

What does Vivani Medical Inc do?

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.